Tuan Ha-Ngoc

Président chez Kew, Inc.

Profil

Tuan Ha-Ngoc is the founder of deNovis, Inc. (founded in 1999) where he held the title of President & Chief Executive Officer in 2002.
He currently holds the position of Executive Chairman at Kew, Inc., Director at Biotechnology Innovation Organization, Director at Phylos, Inc., Director at Harvard School of Dental Medicine, Director at David H.
Koch Institute for Integrative Cancer Research, and Director at Tufts University School of Medicine.
Mr. Ha-Ngoc's former positions include Chairman at AVEO Pharmaceuticals, Inc. (2015), Director at Human Genome Sciences, Inc. (2005-2011), Director at ArQule, Inc. (2002-2006), Director at Boston Philharmonic Orchestra, Director at International Institute of New England, Inc., and Executive Vice President at Genetics Institute LLC (1984-2011).
Mr. Ha-Ngoc also served as Vice President-Strategic Development at Wyeth BioPharma (1998-1999).
He holds an MBA from INSEAD and a graduate degree from Université de Paris IV Paris-Sorbonne.

Postes actifs de Tuan Ha-Ngoc

Sociétés	Poste	Début
Harvard School of Dental Medicine	Directeur/Membre du Conseil	05/04/2011
Biotechnology Innovation Organization	Directeur/Membre du Conseil	-
Tufts University School of Medicine	Directeur/Membre du Conseil	-
David H. Koch Institute for Integrative Cancer Research	Directeur/Membre du Conseil	-
Kew, Inc.	Président	-
Phylos, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Tuan Ha-Ngoc

Sociétés	Poste	Fin
AVEO PHARMACEUTICALS, INC.	Directeur Général	07/01/2015
ARQULE, INC.	Directeur/Membre du Conseil	17/11/2006
deNovis, Inc.	Fondateur	01/01/2002
░░░░░ ░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░ ░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-